Olygose, a Venette (Compiègne), France-based nutrition company, raised €5m in funding.
Backers included CapAgro, Vives II and its existing shareholders Emertec 4, business angels and family offices. In conjunction with the funding, Jérôme Samson, General Manager of CapAgro, joined Olygose’s Supervisory Board.
The company intends to use the funds to to speed up its clinical trials to obtain health claims, increase its production capacity to several thousand tonnes a year, continue with its applicative R&D programs and reinforce its sales teams on an international level, in North America and Asia.
Founded in 2009 by François Delbaere and Laurent Guyard, Olygose develops and produces a range of patented oligosaccharide products extracted from protein-based plants. Its soluble proprietary prebiotic fibres have clinically proven advantages in healthy food, notably in the areas of weight loss, satiety, obesity, diabetes and metabolic syndrome. Applications for its products can be found in everyday foodstuffs (fizzy drinks, yoghurt, confectionery, etc.) and medicalized nutrition for patients with high cardiovascular or metabolic risks.
The company’s clinical programs are based on recent demonstrations of the role of intestinal microbiota in pathologies, notably by the teams of Professor Karine Clément at the Institut de CArdiométabolisme et Nutrition (Cardiometabolism and Nutrition Institute -ICAN) / Pitié Salpétrière Hospital, who is coordinating Olygose’s main clinical trial currently under way.
Olygose has 15 staff.